These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 6240996

  • 1. Comparative microscopic study of cardiotoxicity and skin toxicity of anthracycline analogs.
    Dantchev D, Balercia G, Bourut C, Anjo A, Maral R, Mathé G.
    Biomed Pharmacother; 1984; 38(7):322-8. PubMed ID: 6240996
    [Abstract] [Full Text] [Related]

  • 2. [Ultrastructural study of cardiotoxicity and skin alterations in the golden hamster after treatment with 8 different anthracyclines].
    Dantchev D, Slioussartchouk V, Paintrand M, Bourut C, Hayat M, Mathe G.
    C R Seances Soc Biol Fil; 1979; 173(2):394-413. PubMed ID: 159762
    [Abstract] [Full Text] [Related]

  • 3. Ultrastructural study of the cardiotoxicity and light-microscopic findings of the skin after treatment of golden hamsters with seven different anthracyclines.
    Dantchev D, Slioussartchouk V, Paintrand M, Bourut C, Hayat M, Mathé G.
    Recent Results Cancer Res; 1980; 74():223-49. PubMed ID: 7444141
    [Abstract] [Full Text] [Related]

  • 4. Cardiotoxicity and comparative pharmacokinetics of six anthracyclines in the rabbit.
    Jaenke RS, Deprez-DeCampeneere D, Trouet A.
    Cancer Res; 1980 Oct; 40(10):3530-6. PubMed ID: 6934026
    [Abstract] [Full Text] [Related]

  • 5. Electron microscopic studies of the heart and light microscopic studies of the skin after treatment of golden hamsters with adriamycin, detorubicin, AD-32, and aclacinomycin.
    Dantchev D, Slioussartchouk V, Paintrand M, Hayat M, Bourut C, Mathé G.
    Cancer Treat Rep; 1979 May; 63(5):875-88. PubMed ID: 455329
    [Abstract] [Full Text] [Related]

  • 6. [Comparison of the cardiotoxicity of adriamycin and aclacinomycin A in the rat. Optical and electron microscopic study].
    Bouhour JB, Delajartre AY, Chiffoleau S, Fumoleau P, Nicolas G.
    Arch Mal Coeur Vaiss; 1983 Nov; 76(11):1270-6. PubMed ID: 6419694
    [Abstract] [Full Text] [Related]

  • 7. Relationship between the intracellular accumulation of anthracyclines and effectiveness in vitro and in vivo.
    Tapiero H, Munck JN, Fourcade A.
    Drugs Exp Clin Res; 1986 Nov; 12(1-3):257-64. PubMed ID: 3460752
    [Abstract] [Full Text] [Related]

  • 8. [Japanese-French cooperation in tumor pharmacotherapy: 1970-1990].
    Mathé G.
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1050-70. PubMed ID: 6191671
    [Abstract] [Full Text] [Related]

  • 9. Mutagenicity of eight anthracycline derivatives in five strains of Salmonella typhimurium.
    Marzin D, Jasmin C, Maral R, Mathe G.
    Eur J Cancer Clin Oncol; 1983 May; 19(5):641-7. PubMed ID: 6347692
    [Abstract] [Full Text] [Related]

  • 10. [Cardiotoxicity of daunorubicin and aclacinomycin A in patients with acute leukemia].
    Haruyama H, Shimazaki C, Nakanishi S, Hamami T, Nisio A, Isemura T, Katsume H, Nakagawa M, Ijichi H.
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):516-21. PubMed ID: 6964037
    [Abstract] [Full Text] [Related]

  • 11. Acute anthracycline cardiotoxicity. Comparative morphologic study of three analogues.
    Taylor AL, Applefeld MM, Wiernik PH, Grochow LB, Mader LC, Bulkley BH.
    Cancer; 1984 Apr 15; 53(8):1660-6. PubMed ID: 6582997
    [Abstract] [Full Text] [Related]

  • 12. Antitumor activity of new anthracycline antibiotics, aclacinomycin-A and its analogs, and their toxicity.
    Hori S, Shirai M, Hirano S, Oki T, Inui T, Tsukagoshi S, Ishizuka M, Takeuchi T, Umezawa H.
    Gan; 1977 Oct 15; 68(5):685-90. PubMed ID: 579346
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of dexrazoxane as a cardioprotective agent in patients receiving mitoxantrone- and daunorubicin-based chemotherapy.
    Lemez P, Maresová J.
    Semin Oncol; 1998 Aug 15; 25(4 Suppl 10):61-5. PubMed ID: 9768826
    [Abstract] [Full Text] [Related]

  • 14. Accumulation and metabolism of new anthracycline derivatives in the heart after IV injection into mice.
    Deprez-de Campeneere D, Baurain R, Trouet A.
    Cancer Chemother Pharmacol; 1982 Aug 15; 8(2):193-7. PubMed ID: 6955070
    [Abstract] [Full Text] [Related]

  • 15. Anthracycline cardiomyopathy monitored by morphologic changes.
    Billingham ME, Mason JW, Bristow MR, Daniels JR.
    Cancer Treat Rep; 1978 Jun 15; 62(6):865-72. PubMed ID: 667860
    [Abstract] [Full Text] [Related]

  • 16. [Investigation of the preventive effect of CoQ10 against the side-effects of anthracycline antineoplastic agents].
    Tsubaki K, Horiuchi A, Kitani T, Taniguchi N, Masaoka T, Shibata H, Yonezawa T, Tsubakio T, Kawagoe H, Shinohara Y.
    Gan To Kagaku Ryoho; 1984 Jul 15; 11(7):1420-7. PubMed ID: 6742867
    [Abstract] [Full Text] [Related]

  • 17. Preliminary results of a phase II trial of aclacinomycin in acute leukaemia and lymphosarcoma. An oncostatic anthracyclin that is rarely cardiotoxic and induces no alopecia.
    Mathé G, Bayssas M, Gouveia J, Dantchev D, Ribaud P, Machover D, Misset JL, Schwarzenberg L, Jasmin C, Hayat M.
    Cancer Chemother Pharmacol; 1978 Jul 15; 1(4):259-62. PubMed ID: 373923
    [Abstract] [Full Text] [Related]

  • 18. Phase I-II study of aclacinomycin for a treatment of acute myeloid leukemia.
    Machover D, Gastiaburu J, Delgado M, Goldschmidt E, Hulhoven R, Misset JL, de Vassal F, Tapiero H, Dorval T, Ribaud P.
    Biomed Pharmacother; 1984 Jul 15; 38(7):328-31. PubMed ID: 6596962
    [Abstract] [Full Text] [Related]

  • 19. Potentiation of adriamycin accumulation and effectiveness in adriamycin-resistant cells by aclacinomycin A.
    Tapiero H, Boulé D, Trincal G, Fourcade A, Lampidis TJ.
    Leuk Res; 1988 Jul 15; 12(5):411-8. PubMed ID: 3164087
    [Abstract] [Full Text] [Related]

  • 20. [New anthracycline antibiotics and derivatives].
    Tatsuta K.
    Gan To Kagaku Ryoho; 1984 Dec 15; 11(12 Pt 2):2640-52. PubMed ID: 6594977
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.